Cardiovascular Biomarkers and Subclinical Brain Disease in the Atherosclerosis Risk in Communities Study | Zendy

Razvan T. Dadu | Zendy; Myriam Fornage | Zendy; Salim S. Virani | Zendy; Vijay Nambi | Zendy; Ron C. Hoogeveen | Zendy; Eric Boerwinkle | Zendy; Álvaro Alonso | Zendy; Rebecca F. Gottesman | Zendy; Thomas H. Mosley | Zendy; Christie M. Ballantyne | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiovascular Biomarkers and Subclinical Brain Disease in the Atherosclerosis Risk in Communities Study

Author(s) -

Razvan T. Dadu,

Myriam Fornage,

Salim S. Virani,

Vijay Nambi,

Ron C. Hoogeveen,

Eric Boerwinkle,

Álvaro Alonso,

Rebecca F. Gottesman,

Thomas H. Mosley,

Christie M. Ballantyne

Publication year - 2013

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.001128

Subject(s) - medicine , subclinical infection , disease , stroke (engine) , cardiology , atherosclerotic cardiovascular disease , mechanical engineering , engineering

Cerebrovascular and cardiovascular disease share common risk factors. Our goal was to determine whether levels of N-terminal brain natriuretic peptide (NT-proBNP) and cardiac troponin T measured with a highly sensitive assay (hs-cTnT) are associated with silent brain infarcts (BIs) and white matter lesions (WMLs) on MRI in the Atherosclerosis Risk in Communities (ARIC) study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research